Catheter Ablation News and Research

RSS

Majority of cryoballoon ablation patients show no signs of A-Fib year after procedure

Many patients are responding to a new, minimally invasive way of treating irregular heartbeats by freezing out the bad cells. Atrial fibrillation (A-Fib) is one such heart rhythm disorder, and it's the most common arrhythmia affecting Americans.

13 Sep 2011

Clinical trial to evaluate RMN system for treatment of ischemic Ventricular Tachycardia

Results from the STOP-VT Study were presented at the ESC Congress 2011 today. This is the first ever multi-center, global, prospective trial to evaluate a Remote Magnetic Navigation system for the treatment of ischemic Ventricular Tachycardia.

30 Aug 2011

EAST clinical trial to assess early comprehensive rhythm control therapy for AF

The first patient has been enrolled, in Hamburg, Germany, for the largest pan-European study to determine whether an early comprehensive rhythm control strategy for the treatment of atrial fibrillation (AF) will benefit patients.

3 Aug 2011

Enrollment commences in St. Jude Medical's atrial fibrillation stroke prevention trial

St. Jude Medical, Inc., a global medical device company, today announced that the first patient was enrolled in the EAST (Early comprehensive Atrial fibrillation Stroke prevention Trial) clinical trial.

2 Aug 2011

First cardiac ablation procedure using Thermocool SmartTOUCH catheter performed at Mount Sinai

The Mount Sinai Medical Center has become the first hospital on the east coast to perform a cardiac ablation procedure using the Thermocool Smarttouch Contact Force-Sensing Catheter for the treatment of symptomatic, paroxysmal atrial fibrillation (AF), or periodic rapid and irregular heartbeats.

30 Jul 2011

Endosense completes first patient case utilizing new prototype software

Endosense, a Swiss medical technology company, has announced completion of the first patient case utilizing prototype software that integrates the contact-force data provided by Endosense's TactiCath force-sensing ablation catheter with Siemens Healthcare's electrophysiology solutions.

11 Jul 2011

EHRA, Cardiostim partner to develop common scientific programme committee

EHRA-Europace and Cardiostim, Europe's leading congresses in "electrophysiology" and the treatment of heart rhythm disorders have formed a strategic alliance to ensure the development from year to year of a homogeneous congress programme devised under the direction of a common scientific committee.

30 Jun 2011

Two-pronged 'hybrid' procedure for treatment of atrial fibrillation

Doctors at Washington University School of Medicine in St. Louis are performing a new procedure to treat atrial fibrillation, a common irregular heartbeat.

29 Jun 2011

Mortality, morbidity rates linked with AF remain 'unacceptably high' despite new treatments

Despite recent advances in the treatment of heart rhythm disturbances, mortality and morbidity rates associated with atrial fibrillation (AF) remain "unacceptably high", according to a new report.

27 Jun 2011

ACT's TEMPASURE cardiac ablation catheter receives CE Mark

Advanced Cardiac Therapeutics, Inc., a developer of innovative temperature-sensing cardiac ablation systems, today announced that the company has received CE Mark (Conformité Européenne) clearance for its TEMPASURE™ cardiac ablation catheter. The TEMPASURE system is the world's first RF cardiac ablation catheter to offer both saline irrigation and temperature-sensing technology.

8 Jun 2011

Electrophysiologists use new robotic system to treat cardiac arrhythmias

Cardiac experts who fix arrhythmias, which are electrical problems of the heart, must perform complex catheter procedures while the heart is still beating in order to pinpoint where an electrical malfunction is taking place.

31 Mar 2011

SLEH treats irregular heartbeat with novel minimally invasive cold cryoballoon technology

A physician affiliated with Texas Heart® Institute (THI) at St. Luke's Episcopal Hospital (SLEH) is the first in Houston and among the first in the nation to treat patients for an irregular heartbeat with a new, minimally invasive cryoballoon technology that uses cold rather than heat to interrupt faulty electrical circuits in the heart.

21 Mar 2011

ACT initiates enrollment in TEMPASURE cardiac ablation catheter CE Mark clinical trial

Advanced Cardiac Therapeutics, Inc., a developer of innovative temperature-sensing cardiac ablation systems, today announced that the first patients have been enrolled in a first-in-man CE Mark clinical trial of the safety and performance of the company's TEMPASURE™ cardiac ablation catheter. The TEMPASURE system is the world's first RF cardiac ablation catheter to offer both saline irrigation and temperature-sensing technology.

17 Mar 2011

First U.S. catheter ablation procedure for treatment of AF performed at Mount Sinai

The Mount Sinai Medical Center has become the first hospital in the United States to perform a cardiac catheterization procedure using the TactiCath force-sensing ablation catheter for the treatment of symptomatic paroxysmal atrial fibrillation, or periodic rapid and irregular heartbeats.

11 Mar 2011

Doctors at Beaumont Hospital, Troy perform robotic-assisted maze procedure to correct atrial fibrillation

Doctors at Beaumont Hospital, Troy have performed Michigan's first minimally invasive robotic procedure to correct atrial fibrillation, a prevalent and growing heart rhythm disorder. The new robotic maze procedure is an alternative to open-heart surgery. It's performed through tiny, keyhole incisions with fewer complications and a shorter hospital stay.

4 Mar 2011

CardioFocus completes $30.6M private financing

CardioFocus, Inc., developer of the Endoscopic Ablation System for the transcatheter treatment of Atrial Fibrillation, announced the completion of a $30.6M private financing.

28 Feb 2011

HRS invites NewCardio to present CardioBip system clinical study results at Annual Scientific Meeting

NewCardio, Inc., a cardiovascular diagnostic solutions developer, announced today that the Company has been invited by the Heart Rhythm Society to present results of a recent clinical study showing that recurrent atrial fibrillation was accurately and timely detected in patients who used CardioBip for daily monitoring following catheter ablation procedures.

25 Feb 2011

Elsevier, CJC publish 2011 issue of Canadian Journal of Cardiology

Elsevier and the Canadian Cardiovascular Society announce the publication of the January/February 2011 issue of the Canadian Journal of Cardiology, the first in their partnership. This theme issue focused on atrial fibrillation includes the long-awaited Canadian Cardiovascular Society Atrial Fibrillation Guidelines.

21 Feb 2011

BCVI offers multidisciplinary approach to treat patients with atrial fibrillation

More than 2.6 million Americans suffer from atrial fibrillation —an erratic heartbeat. If left untreated, the condition can lead to stroke or heart failure. For three decades, 58 year old David Ryan was one of the millions of Americans suffering from the disease.

16 Feb 2011

Endosense announces completion of enrollment in EFFICAS I clinical study

Endosense, a Swiss medical technology company focused on improving the efficacy, safety and accessibility of catheter ablation for the treatment of cardiac arrhythmias, has announced enrollment completion in the EFFICAS I clinical study.